Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

62
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
62
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

267
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
267
Pharmacovigilance01:19

Pharmacovigilance

1.4K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.4K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.3K
Ethical Standards II01:23

Ethical Standards II

1.1K
Ethical standards are the backbone of nursing practice, guiding nurses as they interact with patients, families, and colleagues. These standards are crucial for providing safe, empathetic care centered on the patient's needs.
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy...
1.1K
Clinical Trials01:16

Clinical Trials

10.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Midline signaling regulates kidney positioning but not nephrogenesis through Shh.

Developmental biology·2010
Same author

Y chromosomal STR polymorphism in northern Chinese populations.

Biological research·2010
Same author

Construction of NF-κB-targeting RNAi adenovirus vector and the effect of NF-κB pathway on proliferation and apoptosis of vascular endothelial cells.

Molecular biology reports·2010
Same author

Hearing evaluation of intratympanic methylprednisolone perfusion for refractory sudden sensorineural hearing loss.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2010
Same author

Hydrothermal synthesis of nanostructures Bi12TiO20 and their photocatalytic activity on acid orange 7 under visible light.

Chemosphere·2010
Same author

An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles.

Biomaterials·2010

Related Experiment Video

Updated: Nov 21, 2025

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.2K

Data Sharing and Privacy in Pharmaceutical Studies.

Rufan Chen1, Yi Zhang2, Zuochao Dou1

  • 1Department of Bioinformatics, Hangzhou Nuowei Information Technology Co., Ltd, Hangzhou, China.

Current Pharmaceutical Design
|January 13, 2021
PubMed
Summary

Protecting patient privacy is crucial for effective pharmacovigilance systems. This study reviews methods to safeguard medical data, enabling better detection of adverse drug events and reducing public health risks.

Keywords:
Drug usedata privacydata sharingethicspharmacovigilancepolicysocial netowork

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.0K
Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

10.2K

Related Experiment Videos

Last Updated: Nov 21, 2025

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.2K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.0K
Working with Human Tissues for Translational Cancer Research
07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

10.2K

Area of Science:

  • Pharmacovigilance and Public Health
  • Health Informatics
  • Data Privacy

Background:

  • Adverse drug events (ADEs) pose significant public health risks and disease burdens.
  • Comprehensive pharmacovigilance systems are essential for mitigating ADE impacts.
  • Big data approaches enhance ADE detection through novel data sources and health information exchange.

Purpose of the Study:

  • To address the critical challenge of privacy preservation in medical data flow for pharmacovigilance.
  • To explore and review methods for protecting sensitive health information.
  • To facilitate the development of robust pharmacovigilance systems by overcoming data privacy barriers.

Main Methods:

  • Review of existing privacy-preserving techniques relevant to health data.
  • Analysis of challenges and risks associated with big data in pharmacovigilance.
  • Identification of potential solutions for secure health information exchange.

Main Results:

  • The lack of effective privacy-preserving measures is a major impediment to pharmacovigilance.
  • Various privacy protection methods can be employed to secure medical data.
  • Implementing these methods can help overcome barriers to building comprehensive systems.

Conclusions:

  • Enhancing data privacy is paramount for successful big data-driven pharmacovigilance.
  • Urgent action is needed to implement privacy-preserving measures.
  • Reviewed methods offer pathways to secure data sharing and improve public health outcomes.